Assessments of social vulnerability on laryngeal cancer treatment & prognosis in the US

David J Fei-Zhang^#¹, Camaren M Cuenca^#², Angela D Haskins³, Andrew P Stein⁴, David G Lott⁵, Urjeet A Patel⁴, Stephanie S Smith⁴, Amy L Dimachkieh^{3

6}, Nosayaba Osazuwa-Peters^{7

8

9}, Jill N D'Souza¹⁰, Anthony M Sheyn^{11

12

13}, Jeffrey C Rastatter^{4

14}, Daniel C Chelius^{3

6}

Affiliations

¹ Northwestern University Feinberg School of Medicine, Chicago, IL, USA. david.fei-zhang@northwestern.edu.
² Baylor College of Medicine, Houston, TX, USA.
³ Department of Otolaryngology-Head and Neck Surgery, Baylor College of Medicine, Houston, TX, USA.
⁴ Department of Otolaryngology-Head and Neck Surgery, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
⁵ Division of Laryngology, Department of Otolaryngology/Head and Neck Surgery, Mayo Clinic Arizona, Phoenix, AZ, USA.
⁶ Department of Otolaryngology-Head and Neck Surgery, Pediatric Thyroid Tumor Program and Pediatric Head and Neck Tumor Program, Baylor College of Medicine, Texas Children's Hospital, Houston, TX, USA.
⁷ Department of Head and Neck Surgery & Communication Sciences, Duke University School of Medicine, Durham, NC, USA.
⁸ Department of Population Health Sciences, Duke University School of Medicine, Durham, NC, USA.
⁹ Duke Cancer Institute, Duke University, Durham, NC, USA.
¹⁰ Louisiana State University Health Sciences Center Department of Otolaryngology and Division of Pediatric Otolaryngology Children's Hospital of New Orleans, New Orleans, LA, USA.
¹¹ Department of Pediatric Otolaryngology, Le Bonheur Children's Hospital, Memphis, TN, USA.
¹² Department of Otolaryngology-Head and Neck Surgery, University of Tennessee Health Science Center, Memphis, TN, USA.
¹³ Department of Pediatric Otolaryngology, St. Jude Children's Research Hospital, Memphis, TN, USA.
¹⁴ Division of Pediatric Otolaryngology, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL, USA.

^# Contributed equally.

PMID: 40374890
PMCID: PMC12304200
DOI: 10.1038/s41416-025-03056-8

Assessments of social vulnerability on laryngeal cancer treatment & prognosis in the US

David J Fei-Zhang et al. Br J Cancer. 2025 Aug.

. 2025 Aug;133(2):248-254.

doi: 10.1038/s41416-025-03056-8. Epub 2025 May 15.

Authors

Affiliations

¹ Northwestern University Feinberg School of Medicine, Chicago, IL, USA. david.fei-zhang@northwestern.edu.
² Baylor College of Medicine, Houston, TX, USA.
³ Department of Otolaryngology-Head and Neck Surgery, Baylor College of Medicine, Houston, TX, USA.
⁴ Department of Otolaryngology-Head and Neck Surgery, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
⁵ Division of Laryngology, Department of Otolaryngology/Head and Neck Surgery, Mayo Clinic Arizona, Phoenix, AZ, USA.
⁶ Department of Otolaryngology-Head and Neck Surgery, Pediatric Thyroid Tumor Program and Pediatric Head and Neck Tumor Program, Baylor College of Medicine, Texas Children's Hospital, Houston, TX, USA.
⁷ Department of Head and Neck Surgery & Communication Sciences, Duke University School of Medicine, Durham, NC, USA.
⁸ Department of Population Health Sciences, Duke University School of Medicine, Durham, NC, USA.
⁹ Duke Cancer Institute, Duke University, Durham, NC, USA.
¹⁰ Louisiana State University Health Sciences Center Department of Otolaryngology and Division of Pediatric Otolaryngology Children's Hospital of New Orleans, New Orleans, LA, USA.
¹¹ Department of Pediatric Otolaryngology, Le Bonheur Children's Hospital, Memphis, TN, USA.
¹² Department of Otolaryngology-Head and Neck Surgery, University of Tennessee Health Science Center, Memphis, TN, USA.
¹³ Department of Pediatric Otolaryngology, St. Jude Children's Research Hospital, Memphis, TN, USA.
¹⁴ Division of Pediatric Otolaryngology, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL, USA.

^# Contributed equally.

PMID: 40374890
PMCID: PMC12304200
DOI: 10.1038/s41416-025-03056-8

Abstract

Background: Previous social determinants of health (SDoH) studies on laryngeal cancer (LC) have assessed individual factors of socioeconomic status and race/ethnicity but seldom investigate a wider breadth of SDoH-factors for their effects in the real-world. This study aims to delineate how a wider array of SDoH-vulnerabilities interactively associates with LC-disparities.

Methods: This retrospective cohort study assessed 74,495 LC-patients between 1975 and 2017 from the Surveillance-Epidemiology-End Results (SEER) database using the Social Vulnerability Index (SVI) from the CDC, total SDoH-vulnerability from 15 SDoH variables across specific vulnerabilities of socioeconomic status, minority-language status, household composition, and infrastructure/housing and transportation, which were measured across US counties. Univariate linear and logistic regressions were performed on length of care/follow-up and survival, staging, and treatment across SVI scores.

Results: Survival time dropped significantly by 34.37% (from 72.83 to 47.80 months), and surveillance time decreased by 28.09% (from 80.99 to 58.24 months) with increasing overall social vulnerability, alongside advanced staging (OR 1.15; 95%CI 1.13-1.16), increased chemotherapy (OR 1.13; 95%CI 1.11-1.14), decreased surgical resection (OR 0.91; 95%CI 0.90-0.92), and decreased radiotherapy (OR 0.97; 95%CI 0.96-0.99).

Discussion: In this SDoH-study of LCs, detrimental care and prognostic trends were observed with increasing overall SDoH-vulnerability.

PubMed Disclaimer

Conflict of interest statement

Competing interests: The authors declare no competing interests. Ethics approval and consent to participate: The Northwestern University IRB/ethics committee has exempted this study (STU00216871) due to the data queried consisting of publicly available, de-identified data. No consent to participate was necessitated due to the nature of this study comprising retrospective analyses of a publicly available, de-identified national database. Consent to publication: The authors of this manuscript consent to the accuracy of the contents of this manuscript and approve for its submission to be published if accepted.

Figures

**Fig. 1. Relative decreases in months survival with increasing SVI scores.**
Percentage decreases from lowest to highest-SVI quintiles based on mean months survived for total-SVI score and subcomponent SVI-theme subscores.

**Fig. 2. Relative decreases in surveillance months with increasing SVI scores.**
Percentage decreases from lowest to highest-SVI quintiles based on mean surveillance months for total-SVI score and subcomponent SVI-theme subscores.

See this image and copyright information in PMC

References

1. Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024;74:12–49. 10.3322/caac.21820. - PubMed
1. Divakar P, Davies L. Trends in Incidence and Mortality of Larynx Cancer in the US. JAMA Otolaryngol Head Neck Surg. 2023;149:34–41. 10.1001/jamaoto.2022.3636. - PMC - PubMed
1. Batool S, Burks CA, Bergmark RW. Healthcare Disparities in Otolaryngology. Curr Otorhinolaryngol Rep. 2023;11:95–108. 10.1007/s40136-023-00459-0. - PMC - PubMed
1. Baliga S, Yildiz VO, Bazan J, Palmer JD, Jhawar SR, Konieczkowski DJ, et al. Disparities in Survival Outcomes among Racial/Ethnic Minorities with Head and Neck Squamous Cell Cancer in the United States. Cancers (Basel). 2023;15. 10.3390/cancers15061781. - PMC - PubMed
1. Taylor DB, Osazuwa-Peters OL, Okafor SI, Boakye EA, Kuziez D, Perera C, et al. Differential Outcomes among Survivors of Head and Neck Cancer Belonging to Racial and Ethnic Minority Groups. JAMA Otolaryngol Head Neck Surg. 2022;148:119–27. 10.1001/jamaoto.2021.3425. - PMC - PubMed

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group
- PubMed Central

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Assessments of social vulnerability on laryngeal cancer treatment & prognosis in the US

Affiliations

Assessments of social vulnerability on laryngeal cancer treatment & prognosis in the US

Authors

Affiliations

Abstract

Conflict of interest statement

Figures

References

MeSH terms

LinkOut - more resources

Full Text Sources